See Today's Golden Star Stocks 🔥 Free for 7 Days See Today's Golden Star Stocks 🔥 Free for 7 Days
NYSE:AMPE

Ampio Pharmaceuticals Stock News

etoro logo Buy AMPE
*Your capital is at risk
$0.183
+0 (+0%)
At Close: Jun 03, 2026
Forecast Earnings Financials Insider Trading Signals Historical Prices Predictions News Profile

Ampio Pharma Offers Corporate, Clinical, Regulatory Updates

 12:00am, Wednesday, 22'nd May 2019

Ampio Pharmaceuticals, Inc. Option Alert: Jan, 2021 $1 Calls at the Ask: 800 @ $0.3 vs 1169 OI; Ref=$0.5001

 12:00am, Tuesday, 21'st May 2019

Ampio Pharmaceuticals shares are trading lower after the company announced the FDA recommended that the company not start their confirmatory trial without obtaining FDA concurrence on the trial design.

 12:00am, Monday, 29'th Apr 2019

CorMedix: Infected With Hype, Valuation Swollen

 12:00am, Thursday, 25'th Apr 2019

Ampio Pharmaceuticals May Offer, Sell Shares Of Common Stock From Time To Time Up To $24.65M Through Canaccord, Acting As Sales Agent

 12:00am, Monday, 15'th Apr 2019

Ampio Pharmaceuticals Announces Resubmission of Special Protocol Assessment with FDA for a Confirmatory Phase III Clinical Trial of Ampion for Treatment of Patients Afflicted with Osteoarthritis of the Knee

 12:00am, Wednesday, 27'th Mar 2019

Ampio Pharma Reports FDA Provided Guidance Co. 'should complete an additional trial of Kellgren Lawrence Grade 4 osteoarthritis of the knee patients with concurrent controls that would be carried out under a Special Protocol Assessment'

 12:00am, Wednesday, 06'th Mar 2019

Research Report Identifies Wolverine World Wide, Viking Therapeutics, Ampio Pharmaceuticals, ...

 12:00am, Monday, 25'th Feb 2019

Ampio Receives Initial Response From FDA Regarding Co.'s Proposed Trial

 12:00am, Wednesday, 06'th Feb 2019

Helius Medical: A Failed Clinical Trial, Redacted Data, And Questionable Leadership, Points To An Ineffective Device

 12:00am, Tuesday, 29'th Jan 2019

Ampio Pharmaceuticals shares are trading down 23% premarket after the Co announced that the FDA will require a new clinical trial of Ampion, the Co's lead drug for the treatment of severe osteoarthritis of the knee, to support its marketing application.

 12:00am, Thursday, 13'th Dec 2018

Ampio Pharma Announces the FDA's Office of Tissue and Advanced Therapies Will Provide Guidance by Mid-December if Ampio's Trial Portion of Ampion BLA is Complete Or Will Require an Additional Trial

 12:00am, Monday, 26'th Nov 2018

88 Biggest Movers From Yesterday

 12:00am, Thursday, 08'th Nov 2018

Ampio Earlier Announced FDA Has Accepted A Type C Meeting Proposal From Co. And Scheduled Meeting Before End Of November

 12:00am, Wednesday, 07'th Nov 2018

Bragar Eagel & Squire, P.C. is Investigating Certain Officers and Directors of Ampio ...

 12:00am, Tuesday, 30'th Oct 2018
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE